{
    "organizations": [],
    "uuid": "dbfbc7872da3b21a145a4125ed16782b0893e29c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-vistagen-therapeutics-receives-fda/brief-vistagen-therapeutics-receives-fda-fast-track-designation-for-av-101-for-treatment-of-major-depressive-disorder-idUSASB0BZKX",
    "ord_in_thread": 0,
    "title": "BRIEF-Vistagen Therapeutics Receives FDA Fast Track Designation For Av-101 For Treatment Of Major Depressive Disorder",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 3, 2018 / 1:37 PM / in 4 minutes BRIEF-Vistagen Therapeutics Receives FDA Fast Track Designation For Av-101 For Treatment Of Major Depressive Disorder Reuters Staff 1 Min Read \nJan 3 (Reuters) - Vistagen Therapeutics Inc: \n* VISTAGEN THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR AV-101 FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER \n* VISTAGEN THERAPEUTICS INC - ‍ON TRACK TO DOSE FIRST PATIENT IN AV-101 PHASE 2 MDD ADJUNCTIVE TREATMENT STUDY IN Q1 OF 2018​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T15:37:00.000+02:00",
    "crawled": "2018-01-03T15:53:23.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "therapeutic",
        "receives",
        "fda",
        "fast",
        "track",
        "designation",
        "treatment",
        "major",
        "depressive",
        "disorder",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "vistagen",
        "therapeutic",
        "inc",
        "vistagen",
        "therapeutic",
        "receives",
        "fda",
        "fast",
        "track",
        "designation",
        "treatment",
        "major",
        "depressive",
        "disorder",
        "vistagen",
        "therapeutic",
        "inc",
        "track",
        "dose",
        "first",
        "patient",
        "phase",
        "mdd",
        "adjunctive",
        "treatment",
        "study",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}